Prophylaxis played a prominent role in controlling anthrax in animals and protection to individuals from infection. Several vaccines has been produced for the anthrax disease. Louis Pasteur is known as the first microbiologist to produce the first anthrax vaccine in 1881. The vaccines were made of spores from weakened genetic variant of Bacillus anthracis.
Different methods have been adopted to create an enhanced vaccine for humans. The objective is to develop a vaccine that is non reactogenic and involves little administration to perform efficiently. However, the difficult aspect of checking the potency of anthrax vaccine is making an assessment in humans. Tests using this pathogenic bacteria is not safe for humans and animals and requires special precautions.
Humans can become infected from exposure to infected animals or contaminated animal products (including meat, hides, and hair).Anthrax was the first bacterial disease for which effective preventive treatment (prophylaxis) was developed.